The 4th annual Biotech and Money / Medtech and Money World Congress brought together over 635 international life science executives in February 2018.
With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we brought together an incredibly valuable representation of the people that matter to the future of healthcare and life science funding, finance, investment and deal making.
For 2018 we brought a number of new additions to the content and formats, and with 1-2-1 partnering running the length of the congress, it was an eventful two days.
The congress continues to show year-on-year growth whilst maintaining the high calibre and seniority audience that delegates have come to expect since its launch in 2015.
